RENN Capital Group

RENN Capital Group is an investment management firm based in Dallas, Texas, that specializes in providing capital to emerging growth and small-cap companies within the life sciences, healthcare, and technology sectors. The firm is best known for serving as the investment advisor to the RENN Fund (NYSE American: RCG), a publicly traded closed-end fund designed to provide shareholders with capital appreciation through investments in both public and private entities. RENN Capital Group typically utilizes a combination of equity and debt instruments, often participating in private investment in public equity (PIPE) transactions to support clinical-stage biotechnology and medical device firms. Led by founder Russell Cleveland, the firm focuses on bridging the gap between early-stage venture capital and traditional public market investment for micro-cap companies. Although the management of the RENN Fund was transitioned to Horizon Kinetics Asset Management in 2017, the RENN name remains a significant legacy in the healthcare-focused growth capital space.